Financials
- Market Capitalization 948.07 M
- Employee 121
- Founded 2013
- CEO N/A
- Website www.solidbio.com
- Headquarter Delaware, United States
- FIGI BBG00JN4FXG8
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2493 | AVTX Avalo Therapeutics, Inc. - Common Stock | 18.42 USD | -2.59% | -2.90% | +26.25% | +279.79% | 968.26 M USD | ||
| 2502 | JANX Janux Therapeutics, Inc. - Common Stock | 15.78 USD | -2.23% | -0.75% | +14.60% | -39.38% | 962.33 M USD | ||
| 2518 | DBVT DBV Technologies S.A. - American Depositary Shares | 15.92 USD | -0.38% | -7.23% | -13.05% | +64.46% | 942.60 M USD | ||
| 2519 | LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 2.12 USD | -2.30% | -9.40% | +8.72% | +84.35% | 941.70 M USD |
Frequently asked questions about Solid Biosciences Inc. - Common Stock
What is the Solid Biosciences Inc. - Common Stock stock price today?
The current price of Solid Biosciences Inc. - Common Stock (SLDB) is 9.63. Over the past 24 hours, the stock has changed by -0.93%. Follow the SLDB chart for real-time price dynamics.
What is the stock ticker of Solid Biosciences Inc. - Common Stock?
Solid Biosciences Inc. - Common Stock trades under the ticker SLDB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Solid Biosciences Inc. - Common Stock stock going up?
SLDB has changed by -11.33% over the last week, +31.92% over the last month, and +68.95% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Solid Biosciences Inc. - Common Stock net income for the last quarter?
Solid Biosciences Inc. - Common Stock reported net income of -56.74 M for the last quarter. The previous quarter showed -49.79 M, which means net income changed by -13.96%.
How many employees does Solid Biosciences Inc. - Common Stock have?
As of the latest available data, Solid Biosciences Inc. - Common Stock has 121 employees. Workforce size can provide additional context about the company's scale and operations.
What is Solid Biosciences Inc. - Common Stock EBITDA?
Solid Biosciences Inc. - Common Stock EBITDA is -59.58 M, and its EBITDA margin is 3 610.73%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Solid Biosciences Inc. - Common Stock stock?
You can buy Solid Biosciences Inc. - Common Stock (SLDB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Solid Biosciences Inc. - Common Stock stock?
Investing in Solid Biosciences Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SLDB chart and related analysis on metatrader.com as part of your research.